Additionally, PVR expression is an independent poor prognostic factor for OS in patients with cholangiocarcinoma [10], and high PVR mRNA levels are associated with shorter OS and a recurrence-free interval in patients with breast cancer [12]. This evidence concerns the gene PVR and cholangiocarcinoma.